.* Data users need to apply the Form 2 (Application Form for Using NBDC Human Data) to reach the Controlled-Access Data. Learn more
| Research ID | Study Title | Release Date | Type of Study | Platform |
Participants/Materials (Ethnicity) | Data Provider | Type of Data |
|---|---|---|---|---|---|---|---|
|
JGAS00000000002 |
Sequence Data of a SCA31 Patient |
v1:2013/12/01 |
Single Patient NGS (WGS) |
Illumina (HiSeq 2000) |
1 Patient (Japanese) |
Shinichi Morishita |
Controlled-Access (Type I) |
|
JGAS00000000001 |
Molecular Epidemiological Study of Somatic Mutation Profiles of EGFR Mutation Positive Lung Adenocarcinoma |
v1:2014/07/11 |
NGS (Exome) |
Illumina (GAIIx) |
97 Patients (Japanese) |
Koichi Goto |
Controlled-Access (Type I) |
|
DRA001273 JGAS00000000032 DRA003791 JGAS00000000093 JGAS00000000123 |
Genetic Analysis of Hearing Loss and Its Clinical Application |
v1:2014/01/27 v2:2017/02/24 v3:2017/06/19 v4:2018/02/13 |
NGS (Target Capture) |
Life technoligies (Ion PGM/IonProton) Illumina (HiSeq 2000) |
17 UsherSyndrome patients 82 Non-syndromic hearing loss patients (Japanese) |
Shin-ichi Usami |
Un-restricted Access Controlled-Access (Type I) |
|
JGAS00000000004 JGAS00000000106 JGAS00000000146 |
Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance |
v1:2014/01/31 v2:2017/06/05 v3:2017/09/01 v4:2019/02/13 |
NGS (Exome, RNA-seq) Methylation array |
Illumina (HiSeq 2000, HumanMethylation450 BeadChip) |
6 astrocytomas 16 oligodendrogliomas gliomas (17 cerebellar gliomas, 8 cerebral glioblastomas and 14 thalamic gliomas) 94 gliomas (Japanese) |
Nobuhito Saito (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000005 |
Gene Expression of Human Th17 Cells Before and After Activation |
v1:2015/02/12 |
NGS (RNA-seq) |
Applied BioSystems (AB5500 GA) |
1 Participant (4 Samples) (Japanese) |
Sanju Iwamoto |
Controlled-Access (Type I) |
|
JGAS00000000007 |
Research for genetic causes and mechanisms of Hirschsprung's
|
v1:2018/01/29 |
NGS (Exome) |
Illumina (HiSeq 2000) |
5 Patients with Hirschsprung's diseases and 6 their families (Japanese) |
Hiroshi Matsufuji |
Controlled-Access (Type I) |
|
DRA003802 |
DNA Methylation Analysis of Early Human Embryos |
v1:2014/12/24 v2:2015/01/07 v3:2015/08/03 |
NGS (PBAT) |
Illumina (HiSeq 2000/2500) |
11 Libraries (Japanese) |
Takahiro Arima |
Un-restricted Access |
|
JGAS00000000008 |
Research for candidate genes of splenic epidermoid cyst. |
v1:2015/06/23 |
NGS (Exome) |
Illumina (HiSeq 2000) |
8 Splenic epidermoid cysts (Japanese) |
Hiroshi Matsufuji |
Controlled-Access (Type I) |
|
JGAS00000000015 |
Integrated hepatitis B virus is epigenomically regulated by the methylation status of the human genome |
v1:2015/10/07 |
NGS (Target Capture) |
Roche GS FLX Titanium |
2 Cell lines 8 HB-HCC primary tissues (Japanese) |
Hiroyuki Yamamoto |
Controlled-Access (Type I) |
|
JGAS00000000012 |
Nagahama Zero-ji Preventive Cohort Project |
v1:2015/08/19 |
SNP-chip Control Set Cohort |
Illumina (Human610-Quad, HumanOmni2.5-4/2.5-8/2.5S-8, HumanExome-12, HumanCoreExome-12) |
3712 Participants (Japanese) |
Fumihiko Matsuda |
Controlled-Access (Type I) |
|
Japan PGx Data Science Consortium Database |
v1:2014/10/16 |
SNP-chip Control Set |
Illumina (HumanOmni2.5-8) |
2994 Participants (Japanese) |
Koji Suematsu |
Un-restricted Access |
|
|
JGAS00000000101 JGAS00000000114 JGAS00000000140 |
Bio Bank Japan project |
v1:2014/09/30 v2:2015/12/28 v3:2016/01/28 v4:2016/02/02 v5:2017/05/18 v6:2017/09/08 v7:2018/04/04 v8:2018/05/01 v9:2018/08/07 v10:2018/08/13 v11:2018/10/16 v12:2018/12/10 v13:2019/01/25 v14:2019/03/26 |
SNP-chip Case-Control NGS (WGS, Target Capture) |
Illumina (Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HiSeq2500) Perlegen Sciences (high-density oligonucleotide arrays) Hologic Japan (Invader) |
1666 MIs and 3198 ctrls 934 ctrls (JSNP) 35 diseases (JSNP) 182 esophageal cancers (JSNP) 92 ALSs (JSNP) 9817 T2DMs and 6763 ctrls 5646 T2DMs and 19,420 ctrls 1472 ADs and 7966 ctrls 8180 AFs and 28,612 ctrls 158,284 individuals for BMI study 182,505 individuals' genotype data 3980 POAGs and 18,815 ctrls 162,255 individuals for 58 quantitative traits study 67,029 females with information on age at menarche 43,861 females with information on age at menopause 1,026 individuals for WGS 7,104 breast cancer patients and 23,731 controls 2,809 T2DM with diabetic nephropathy patients and 5,592 T2DM ctrls 36,614 T2DMs and 155,150 ctrls 165,436 Japanese individuals with information on smoking behaviour (Japanese) |
Michiaki Kubo |
Un-restricted Access Controlled-Access (Type I) |
|
JGAS00000000159 |
Construction of the Whole-genome Reference Panel of 3552 Japanese Individuals |
v1:2014/10/14 v2:2018/12/27 v3:2019/01/11 |
NGS (WGS) |
Illumina (HiSeq 2500) |
3552 Participants (Japanese) |
Masayuki Yamamoto (ToMMo) |
Un-restricted Access |
|
DRA002604 |
Epigenome analysis of proteins expressed in human testis |
v1:2016/09/30 |
NGS (ChIP-seq, RNA-seq) |
Illumina (HiSeq 1500) |
1 Participant (4 Samples) (Japanese) |
Yasuyuki Ohkawa |
Un-restricted Access |
|
JGAS00000000021 |
Exome sequencing of primary central nervous system lymphoma |
v1:2016/02/22 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2000) |
41 PCNSLs (Japanese) |
Hiroyuki Mano |
Controlled-Access (Type I) |
|
JGAS00000000009 |
Genetic analysis in neurodegenerative disorders |
v1:2015/02/03 |
NGS (Exome) |
Illumina (HiSeq 2000) |
14 MSAs and 7 Controls (Japanese) |
Shoji Tsuji |
Controlled-Access (Type I) |
|
JGAS00000000011 |
Systematic identification of long non-coding RNAs potentially involved in gastrointestinal cancer |
v1:2015/04/01 |
NGS (RNA-seq) Tumor vs. Matched-Normal |
Illumina (HiSeq 2500) |
17 GICs (32 Samples) (Japanese) |
Yasuhisa Shinomura (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000013 |
Genetic Analysis in Amyotrophic Lateral Sclerosis |
v1:2015/01/08 |
NGS (Exome) |
Illumina (HiSeq 2000) |
11 ALSs (Japanese) |
Fumiaki Tanaka (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000014 |
Genetic Analysis in Psychiatric Disorders |
v1:2015/01/08 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Healthy Monozygotic Twins 3 Pairs [6 Participants] (Japanese) |
Tadafumi Kato (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000017 |
Analysis of the Molecular Mechanism for Developing Donor-Origin Leukemia after Allogeneic Stem Cell Transplantation. |
v1:2015/02/02 |
NGS (Exome) |
Illumina (HiSeq 2000) |
1 DCL (5 Samples from Each Stage) 1 Donor (Japanese) |
Hitoshi Kiyoi (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000016 |
Genetic Analysis in Lifestyle-Related Disease, Arteriosclerotic Disease, and Aging-Related Diseases |
v1:2015/01/28 |
NGS (Exome) |
Illumina (HiSeq 2000) |
30 Hypertensions (Japanese) |
Tetsurou Miki (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000023 |
Comprehensive Analysis of Genetic Alterations in Hematological Malignancies |
v1:2015/04/16 |
NGS (Exome) |
Illumina (GAIIx, Hiseq 2000/2500) |
13 MDSs and 1 CMML (Japanese) |
Seishi Ogawa (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000024 JGAS00000000040 |
Identification of genetic polymorphism on aggressive periodontitis |
v1:2016/07/28 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Periodontitis patients (Japanese) |
Shinya Murakami |
Controlled-Access (Type I) |
|
JGAS00000000018 |
Biobank Japan Project |
v1:2015/06/02 v2:2018/06/05 |
SNP-chip |
Illumina (HumanOmniExpress BeadChip, HumanExome BeadChip, ImmunoChip, HumanHap550v3 Genotyping BeadChip) |
908 Participants (Japanese) |
Michiaki Kubo (BBJ) |
Controlled-Access (Type I) |
|
Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome |
v1:2016/03/09 |
SNP-chip Case-Control |
Affymetrix (Axiom ASI) |
117 SJSs and 691 controls (Japanese) |
Mayumi Ueta (Genome Science) |
Un-restricted Access |
|
|
JGAS00000000022 |
The Molecular Biological Analysis about Occurrence and Malignant Transformation in gynecological carcinogenesis |
v1:2015/04/21 |
SNP-chip CNV Analysis |
Affymetrix (Human Mapping 250K Nsp Array) |
57 OvarianCarcinomas (Japanese) |
Katsutoshi Oda (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000042 |
Constructing database of magnetic resonance imaging of the brain and the ancillary clinical information for multisite collaboration studies |
v1:2015/11/20 |
Neuroimage Clinical Info |
Philips (Achieva) |
129 normal controls, 37 schizophrenia, 8 unipolar and 2 bipolar disorders (Japanese) |
Kiyoto Kasai |
Controlled-Access (Type I) Un-restricted Access |
|
JGAS00000000026 JGAS00000000027 JGAS00000000028 |
Standard epigenome mapping in human epithelial cells of the digestive and urogenital organs (HPC series) |
v1:2016/07/22 |
NGS (WGBS ChIP-seq RNA-seq) |
Illumina (HiSeq 2000/2500) |
8 partial hepatectomy specimens (Japanese) |
Yae Kanai (IHEC) |
Controlled-Access (Type I) |
|
DRA003516 |
Functional analysis of two types of exosome in human whole saliva |
v1:2015/05/01 |
NGS (RNA-seq) |
Illumina (GAIIx) |
1 Participant (3 Samples) (Japanese) |
Ryohei Yanoshita |
Un-restricted Access |
|
JGAS00000000037 |
Identification of novel therapeutic targets of small cell lung cancer by comprehensive genomic analyses |
v1:2015/10/01 |
NGS (Exome) |
Illumina (HiSeq 2000) |
51 SCLCs (Japanese) |
Koichi Goto (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000036 JGAS00000000046 JGAS00000000088 |
Genome wide analysis of gene mutations in solid tumors |
v1:2015/09/16 v2:2017/12/26 |
NGS (Exome, Target Capture, RNA-seq) SNP-chip Methylation array |
Illumina (HiSeq 2000/2500, Miseq, Infinium MethylationEPIC) Affymetrix (GeneChip Human Mapping 250k Nspl, CytoScan HD arrays) |
16 RMSs 7 PPBs 522 NBs 39 neuroblastoma cell lines 10 PBLs (Japanese) |
Junko Takita (P-DIRECT) |
Controlled-Access (Type I) |
|
DRA003736 |
Performance Comparison of Four Commercial Human Whole-Exome Capture Platforms |
v1:2015/08/01 |
NGS (Exome) Platform comparison |
Illumina (HiSeq 2500) |
2 HapMap-JPT samples (Japanese) |
Michiaki Kubo |
Un-restricted Access |
|
JGAS00000000035 |
Diagnostic feasibility study for pathological prediction with rheumatoid arthritis-susceptible genes and genomic regions identified by the association analysis using microsatelite markers |
v1:2015/09/24 |
NGS (Exome) |
Illumina (HiSeq 2000) |
39 RAs 10 Controls (pooled) (Japanese) |
Shigeki Mitsunagai (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000041 |
Genetic analysis in an inherited cardiac arrhythmia |
v1:2015/11/18 |
NGS (Exome) |
Illumina (HiSeq 2000) |
11 Patients with an inherited cardiac arrhythmia (Japanese) |
Naomasa Makita (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000039 |
Analysis of TKI resistant mechanism for gastrointstinal stromal tumor (GIST) |
v1:2016/12/27 |
NGS (Exome) |
Illumina (HiSeq 1500) |
4 Imatinib resistant GIST (Japanese) |
Tsuyoshi Takahashi |
Controlled-Access (Type I) |
|
JGAS00000000038 |
Epigenomic analysis of the human placenta |
v1:2016/09/16 |
NGS (WGS, Exome, RNA-seq, BS-seq) |
Illumina (HiSeq 2500) |
28 human placenta 26 maternal blood samples (Japanese) |
Takahiro Arima (IHEC) |
Controlled-Access (Type I) |
|
JGAS00000000052 |
Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies |
v1:2017/01/12 |
NGS (Exome, Target Capture) |
Illumina (HiSeq 2000) |
33 primary HCC (Japanese) |
Shinji Tanaka (P-DIRECT) |
Controlled-Access (Type I) |
|
Genome analysis for elucidation of genetic factors in orofacial traits and diseases |
v1:2016/03/02 |
NGS (WGS) |
Illumina (HumanOmniExpress BeadChip) |
146 TMJ and 374 controls 149 third molar agenesis and 338 controls (Japanese, Korean) |
Tetsutarou Yamaguchi (Genome Science) |
Controlled-Access (Type I) |
|
|
JGAS00000000051 |
Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) |
v1:2016/01/29 |
Neuroimage Clinical Info |
234 MCI 154 AD 149 healthly controls (Japanese) |
Takeshi Iwatsubo |
Controlled-Access (Type I) Un-restricted Access |
|
|
JGAS00000000047 |
Transcriptome analysis of acute lymphoblastic leukemia in adolescents and young adults |
v1:2016/03/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2000/2500) |
99 Ph(-) ALL 3 Ph(+) ALL 5 cell lines 8 normal hematopoietic cells (Japanese) |
Hiroyuki Mano (P-DIRECT) |
Controlled-Access (Type I) |
|
DRA004251 |
Whole exome sequencing on ampullary carcinomas |
v1:2016/02/05 |
NGS (Exome) |
Illumina (HiSeq 2000/2500) |
60 Patients with ampullary cancer (28 Japanese patients and 32 American patients) |
Shinich Yachida |
Un-restricted Access |
|
JGAS00000000053 |
Transcriptome analysis of Hepatitis B for drug discovery and clinical applications |
v1:2016/09/30 |
NGS (CAGE-seq) |
Illumina (HiSeq 2000) |
8 HBV (Genotype C) positive patients (Japanese) |
Tomokazu Matsuura |
Controlled-Access (Type I) |
|
JGAS00000000062 |
Identification of new molecular targets with profiling of malignant mesothelioma |
v1:2016/07/20 |
NGS (Exome) |
Illumina (HiSeq 2000/2500) |
38 malignant mesothelioma (Japanese) |
Takashi Nakano (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000059 |
Genetic and epigentic analysis of non-alcoholic fatty liver disease |
v1:2017/02/20 |
NGS (RNA-seq) Methylation array |
Illumina (HiSeq 2500, Human Methylation 450K BeadChip) |
64 NAFLD patients (Japanese) |
Kikuko Hotta (Genome Science) |
Controlled-Access (Type I) |
|
Genome and Multi-layer omics reference panels using blood samples from a population-based cohort study |
v1:2018/03/30 |
NGS (WGS, WGBS, RNA-seq) |
Illumina (HiSeq 2500/X) |
197 participants (Japanese) |
Atsushi Shimizu |
Un-restricted Access |
|
|
JGAS00000000091 |
Identification of genetic mutations characteristic for recurrence and metastasis of colorectal cancer. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (Hiseq 2000) |
89 colorectal cancers (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000104 |
Identification of genetic mutations characteristic for recurrence of serous ovarian cancer |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
65 ovarian cancer (Japanese) |
Kazuyoshi Kato (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000075 |
Identification of genetic mutations characteristic for recurrence and metastasis of breast cancer |
v1:2018/04/03 |
NGS (Exome) |
Illumina (HiSeq 2000) |
65 recurrent / metastatic breast cancer patients (Japanese) |
Yoshio Miki (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000057 |
Searching causative genes of familial tumors using whole genome / exome sequencing |
v1:2017/02/20 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Siblings developed multiple primary lung cancers (Japanese) |
Kikuya Kato |
Controlled-Access (Type I) |
|
JGAS00000000061 |
Construction of Geriatric Oncology Database for establishment of the Treatment Algorithm: Clinical Data and Questionnaire Survey Results in JapaneseElderly Cancer Patients Retrospective study |
v1:2016/08/26 |
Direct sequencing TaqMan qRT-PCR COBRA cDNA microarray Clinical data Treatment data |
GA 3130 LightCycler 480II Whole Human Genome Microarray 4x44K |
[GENOME] 106 colorectal cancer 62 gastric cancer 173 lung cancer [Retrospective] 313 colorectal cancer 166 gastric cancer 344 lung cancer 300 diabetes and nephropathy 357 cardiovascular disorder 49 respiratory dysfunction (Japanese) |
Masahiko Nishiyama |
Controlled-Access (Type I) |
|
JGAS00000000089 |
Shuttle system between petient-derived xenograft and ex vivo culture for innovative platform of evaluating drug sensitivity |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
8 colorectal cancer 2 lung cancer 2 small cell carcinoma of uterine cervix (Japanese) |
Masahiro Inoue (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000076 |
Project for Development of Innovative Research on Cancer Therapeutics; identifiying the predictive factors for response to chemoherapy in ovarian cancer |
v1:2017/05/18 |
NGS (Exome) |
Illumina (HiSeq 2000) |
55 ovarian clear cell carcinoma patients (Japanese) |
Toru Sugiyama (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000065 |
Cancer genomics for elucidation of molecular mechanisms of carcinogenecis and progression in lung cancer |
v1:2017/07/10 |
NGS (PCR amplicon Seq) |
Nanopore (MinION) |
8 lung adenocarcinoma patients (Japanese) |
Takashi Kono |
Controlled-Access (Type I) |
|
JGAS00000000064 |
RNA expression profiling of neuromuscular diseases and viral diseases |
v1:2016/12/09 |
NGS (small RNA-seq) |
Illumina (HiSeq 2500) |
3 Neuromuscular disease (control group) (Japanese) |
Takanori Yokota |
Controlled-Access (Type I) |
|
JGAS00000000115 |
Molecular analysis of Birt-Hogg-Dube syndrome: Identification of new diagnostic marker and therapeutic target |
v1:2018/05/11 |
NGS (Exome) |
Illumina (HiSeq 2000) |
15 Birt-Hogg-Dube associated kidney cancer (Japanese) |
Masahiro Yao (P-DIRECT) |
Controlled-Access (Type I) |
|
Identification and functional analyses of susceptibility genes to narcolepsy and other sleep disorders |
v1:2017/12/26 |
SNP-chip |
Affymetrix (SNP Array 6.0) |
409 narcolepsy patients 1562 controls (Japanese) 125 essential hypersomnia patients 562 controls (Japanese) |
Katsushi Tokunaga |
Unrestricted-access |
|
|
Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database |
v1:2018/02/27 v2:2018/09/25 |
SNP-chip |
Affymetrix (SNP Array 6.0, Axiom ASI) |
78 NVR, 64 VR, 51 SVR 107 patients with the decrease of PLT 196 patients without the decrease of PLT 94 HCV patients with an Hb reduction 209 HCV patients without Hb reduction 123 patients who developed HCC after eradication of HCV 333 patients who did not develop HCC after eradication of HCV (Japanese) |
Yasuhito Tanaka |
Unrestricted-access |
|
|
Search for susceptibility genes to hepatitis virus B-related diseases |
v1:2017/09/25 v2:2019/02/19 |
SNP-chip |
Affymetrix (SNP Array 6.0, Axiom ASI) |
181 HBV carriers 185 spontaneously HBV-resolved individuals 184 controls 473 HBV-positive HCC patients 516 HBV carriers (chronic hepatitis and asymptomatic carriers) (Japanese) |
Masashi Mizokami |
Unrestricted-access |
|
|
Genome-wide search for susceptibility genes to primary biliary chirrosis |
v1:2016/10/05 |
SNP-chip |
Affymetrix (Axiom ASI) |
487 PBCs 476 controls (Japanese) |
Minoru Nakamura |
Unrestricted-access |
|
|
JGAS00000000120 |
Genome-wide analysis of SNPs in Healthy Japanese |
v1:2017/09/26 v1:2017/10/03 |
SNP-chip Control Set |
Affymetrix (Axiom ASI/6.0) |
419 Participants (Japanese) |
Katsushi Tokunaga |
Unrestricted-access Controlled-Access (Type I) |
|
JGAS00000000070 |
Genome-wide analysis for biomarker exploration (lung cancer) |
v1:2016/10/28 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
97 lung cancer tissues (Japanese) |
Yoshihide Hayashizaki |
Controlled-Access (Type I) |
|
JGAS00000000108 |
Molecular biological research affecting on long-term treatment to malignant tumors derived from the chest or abdomen Genomic analysis of environment-associated tumors |
v1:2017/10/16 |
Array CGH, NGS (WGS, Target Capture) |
Illumina (MiSeq, HiSeq X-10) |
32 malignant mesotheliomas (Japanese, Americans) |
Masaki Ohmuraya |
Controlled-Access (Type I) |
|
JGAS00000000073 JGAS00000000107 |
Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface |
v1:2017/09/25 v2:2017/12/26 v3:2018/06/26 |
NGS (WGBS ChIP-seq RNA-seq small RNA-seq) |
Illumina (HiSeq 1500/2500) |
placenta and uterus cells, trophoblast stem cells: total 39 samples (Japanese) |
Hiroyuki Sasaki (IHEC) |
Controlled-Access (Type I) |
|
JGAS00000000077 JGAS00000000096 |
Global analysis of TGF-beta family signaling in cancer cells |
v1:2019/02/08 |
NGS (RNA-seq, WGS) |
Illumina (Genome Analyzer IIx) Thermo Fisher Scientific (Ion Proton) |
2 glioblastomas (Japanese) |
Kohei Miyazono |
Controlled-Access (Type I) |
|
JGAS00000000078 JGAS00000000079 JGAS00000000080 |
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer (COC series) |
v1:2016/11/18 |
NGS (WGBS ChIP-seq RNA-seq) |
Illumina (HiSeq 2000/2500) |
12 normal human absorptive epithelial cells (Japanese) |
Yae Kanai (IHEC) |
Controlled-Access (Type I) |
|
JGAS00000000095 JGAS00000000105 JGAS00000000113 |
Genomic and epigenomic analysis of different types of cancer |
v1:2017/09/04 v2:2018/01/22 v3:2019/02/12 |
NGS (WGS, Exome, RNA-seq), Methylation array, SNP-chip |
Illumina (HiSeq 2000/2500, Infinium Human MethylationEPIC BeadChip, HumanOmni2.5-8 BeadChip) |
68 breast cancer patients 43 lung adenocarcinoma patients 150 colorectal cancers (Japanese) |
Hiroyuki Mano |
Controlled-Access (Type I) |
|
JGAS00000000092 |
Genetic analysis of colorectal precancerous lesion and early colorectal cancer to investigate mechanism of carcinogenesis of colorectal cancer |
v1:2018/07/30 |
NGS (Exome) |
Illumina (HiSeq 2500) |
10 cases of colorectal adenomas or PCRCs (Japanese) |
Koshi Mimori |
Controlled-Access (Type I) |
|
JGAS00000000090 |
Comprehensive analysis of genetic alterations in hematological malignancies |
v1:2017/05/25 |
NGS (RNA-seq) |
Illumina (HiSeq 2500) |
123 pediatric T-ALL patients (Japanese) |
Junko Takita |
Controlled-Access (Type I) |
|
JGAS00000000094 |
Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome |
v1:2018/05/25 |
NGS (Exome) |
Illumina (HiSeq 2500) |
5 patients with aplastic anemia with uniparental disomy in 6p (Japanese) |
Shinji Nakao (Genome Science) |
Controlled-Access (Type I) |
|
JGAS00000000085 |
Expression quantitative trait loci analysis using human immune cells |
v1:2017/04/24 |
RNA-seq SNP-chip |
Illumina (Hiseq 2500, Infinium OmniExpressExome BeadChips) |
105 healthy volunteers (Japanese) |
Kazuhiko Yamamoto |
Unrestricted-access Controlled-Access (Type I) |
|
JGAS00000000098 |
Identification of gene mutations in primary immunodeficiency characterized by EBV-associated B-cell lymphoma |
v1:2018/05/11 |
NGS (Target Capture) |
Illumina (Miseq) |
2 patients with primary immunodeficiency (Japanese) |
Yasumasa Iwatani |
Controlled-Access (Type I) |
|
JGAS00000000109 |
Genome sequencing analysis for biliary tract cancer |
v1:2018/02/27 |
NGS (WGS, Exome) |
Illumina (Hiseq 2000/2500) |
95 biliary tract cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
|
JGAS00000000099 |
Establish induced pluripotent stem (iPS) cells from patients with Gorlin syndrome and elucidate the pathology |
v1:2017/10/02 |
NGS (Exome) |
Illumina (Hiseq 2500/4000) |
4 patients with Gorlin syndrome (Japanese) |
Toshifumi Azuma |
Controlled-Access (Type I) |
|
JGAS00000000111 |
Search for new susceptibility genetic factors associated with psychiatric disorders |
v1:2017/06/26 |
Methylation array |
Illumina (Infinium HumanMethylation450) |
48 panic disorder patients 48 healthy controls (Japanese) |
Katsushi Tokunaga |
Controlled-Access (Type I) |
|
JGAS00000000103 |
Analysis of gastric cancer genome and its clinicopathological significance |
v1:2017/07/31 |
NGS (RNA-seq, Amplicon-seq) |
Illumina (HiSeq 2000, MiSeq) |
30 diffuse-type gastric carcinomas (Japanese) |
Shumpei Ishikawa |
Controlled-Access (Type I) |
|
JGAS00000000112 (JGA00000000122) |
Basic research for the establishment and characterization of human trophoblast stem cells |
v1:2017/12/14 |
NGS (WGBS ChIP-seq RNA-seq miRNA-seq) |
Illumina (HiSeq 1500/2500) |
2 trophoblast stem cells (Japanese) |
Takahiro Arima |
Controlled-Access (Type I) |
|
Research on statistical genetics using B cell lines of Japanese ancestry |
v1:2017/12/18 |
SNP-chip |
Illumina (HumanCoreExome BeadChip) |
282 psoriasis patients 426 controls (Japanese) |
Yukinori Okada |
Unrestricted-access |
|
|
JGAS00000000125 |
Epigenetics analysis of neurodegenerative diseases |
v1:2017/12/11 |
Methylation array |
Illumina (Human Methylation 450K BeadChip) |
30 Alzheimer's disease patients 30 healty controls (Japanese) |
Atsushi Iwata |
Controlled-Access (Type I) |
|
JGAS00000000124 |
Genome-wide analysis for biomarker exploration (endometrial cancer) |
v1:2017/12/11 |
NGS (CAGE-seq) Sanger-seq |
Illumina (HiSeq 2500) Thermo Fisher Scientific (ABI) 3500 Genetic Analyzer |
17 endometrial cancer patients (Japanese) |
Yoshihide Hayashizaki |
Controlled-Access (Type I) |
|
JGAS00000000126 |
Analysis for mechanism of onset and progress for NASH |
v1:2019/01/31 |
SNP-chip |
Illumina (Human610-Quad BeadChip, HumanCoreExome BeadChip, HumanOmni2.5-Quad BeadChip) |
902 NAFLDs 7672 healty controls (Japanese) |
Fumihiko Matsuda |
Controlled-Access (Type I) |
|
JGAS00000000129 |
Study for exome sequencing in familial epidermal growth factor receptor-mutant lung cancer |
v1:2018/04/06 |
NGS (Exome) |
Illumina (Hiseq 2000) |
3 EGFR-mutant lung cancers (Japanese) |
Toshiaki Kikuchi (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000127 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2018/11/05 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
3 Crohn's diseases 4 Colorectal cancers (normal cells) (Japanese) |
Shimon Sakaguchi |
Controlled-Access (Type I) |
|
Identification of the disease and drug susceptibility genes for the Childhood Idiopathic Nephrotic Syndrome |
v1:2018/04/27 |
SNP-chip |
Affymetrix (Japonica Array v1) |
224 Childhood Idiopathic Nephrotic Syndrome patients 419 healthy controls (Japanese) |
Kazumoto Iijima |
Unrestricted-access |
|
|
JGAS00000000153 |
A study on comprehensive genome and proteome analyses of the chronic eosinophillic inflammatory diseases. |
v1:2018/10/29 |
NGS (RNA-seq) |
Illumina (Hiseq 2000) |
6 chronic rhinosinusitis with nasal polyps (Japanese) |
Shigeharu Fujieda |
Controlled-Access (Type I) |
|
JGAS00000000131 |
Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology |
v1:2018/04/06 |
NGS (ChIP-seq) |
Illumina (Hiseq 2500) |
2 CHARGE syndrome patients (Japanese) |
Hideyuki Okano |
Controlled-Access (Type I) |
|
JGAS00000000150 |
Comprehensive genetic analyses of bone marrow cells in POEMS syndrome Analyses of molecular mechanisms of hematological malignancies and bone marrow niche |
v1:2019/01/18 |
NGS (Exome, Target Capture, RNA-seq) |
Illumina (HiSeq 1500/2500, MiSeq) |
20 POEMS syndromes 4 MMs 5 MGUSs (Japanese) |
Emiko Sakaida |
Controlled-Access (Type I) |
|
JGAS00000000132 |
The epigenetics of neurodevelopmental disorders |
v1:2018/11/20 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion Proton) |
6 Williams syndromes 8 healthy contorols (Japanese) |
Ryo Kimura |
Controlled-Access (Type I) |
|
JGAS00000000137 |
Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level |
v1:2018/09/07 |
NGS (WGS) |
Illumina (Hiseq 2500) |
9 trios of the father exposed to dioxin and his wife and child with mental retardation (total 27 individuals) (Vietnamese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
|
JGAS00000000086 |
Identification of genetic mutations characteristic for recurrence and metastasis of gastric cancer. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (Hiseq 2000) |
75 gastric cancers (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-Access (Type I) |
|
JGAS00000000087 |
Identification of genetic mutations characteristic for recurrence and metastasis of B cell lymphoma. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (Hiseq 2000) |
60 B cell lymphomas (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-Access (Type I) |
|
Construction of integrated clinical genome database regarding hepatitis B related diseases |
v1:2018/05/22 |
SNP-chip |
Affymetrix (Axiom ASI) |
1,193 individuals vaccinated with a HB vaccine (Japanese) |
Masashi Mizokami |
Unrestricted-access |
|
|
JGAS00000000144 |
a multicenter study of susceptibility genes to type 1 diabetes |
v1:2018/12/21 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
32 type 1 diabetes patients (Japanese) |
Hiroshi Ikegami |
Controlled-Access (Type I) |
|
JGAS00000000136 |
Research for drug discovery and elucidation of pathophysiology using disease-specific iPS cells |
v1:2018/07/10 |
NGS (Exome) |
Illumina (HiSeq 1500) |
1 RALD patient (Japanese) |
Makoto Otsu |
Controlled-Access (Type I) |
|
DRA007187 |
Diagnosis of imprinting disorders and safety evaluation of assisted reproduction technologies (ART) |
v1:2019/02/19 |
NGS (RRBS) |
Illumina (HiSeq 2500) |
5 SRS patients born after ART 5 spontaneously conceived SRS patients 10 spontaneously conceived children (Japanese) |
Takahiro Arima |
Un-restricted Access |
|
JGAS00000000151 |
Genome sequencing analysis for liver cancer |
v1:2018/10/22 |
NGS (WGS, RNA-seq) |
Illumina (Hiseq 2000/2500, Genome Analyzer IIx) |
270 liver cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
|
Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology |
v1:2018/12/14 |
NGS (Target Capture) |
Illumina (MiSeq) |
990 patients with psychiatric/neurological disorders and cancers (Japanese) |
Taisei Mushiroda |
Unrestricted-access |
|
|
JGAS00000000160 |
Tohoku Medical Megabank Organization cohort study |
v1:2018/12/14 |
SNP-chip |
Illumina (Infinium OmniExpressExome-8) |
9,187 participants (Japanese) |
Masao Nagasaki |
Controlled-Access (Type I) |
# You can search the data in the European Sequence Read Archive (ERA) and the Sequence Read Archive (SRA) through the DDBJ Sequence Read Archive (DRA) site.
# You can also search the data in SRA through the Database Center for Life Science (DBCLS) SRA web site.
